Cargando…

Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges

Severe viral pneumonia is a significant cause of morbidity and mortality globally, whether due to outbreaks of endemic viruses, periodic viral epidemics, or the rarer but devastating global viral pandemics. While limited anti-viral therapies exist, there is a paucity of direct therapies to directly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masterson, C. H., Ceccato, A., Artigas, A., dos Santos, C., Rocco, P. R., Rolandsson Enes, S., Weiss, D. J., McAuley, D., Matthay, M. A., English, K., Curley, G. F., Laffey, J. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718182/ https://www.ncbi.nlm.nih.gov/pubmed/34970706 http://dx.doi.org/10.1186/s40635-021-00424-5

Ejemplares similares

Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
por: Rolandsson Enes, Sara, et al.
Publicado: (2021)

The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing
por: Dunbar, Hazel, et al.
Publicado: (2021)

Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury
por: Hayes, Mairead, et al.
Publicado: (2015)

Multiple Dosing and Preactivation of Mesenchymal Stromal Cells Enhance Efficacy in Established Pneumonia Induced by Antimicrobial-Resistant Klebsiella pneumoniae in Rodents
por: Byrnes, Declan, et al.
Publicado: (2023)

Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis
por: Su, Yue, et al.
Publicado: (2023)

Clinical Application of Stem/Stromal Cells in COPD
por: Enes, Sara Rolandsson, et al.
Publicado: (2019)

Lung inflammatory environments differentially alter mesenchymal stromal cell behavior
por: Abreu, Soraia C., et al.
Publicado: (2019)

Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells
por: Abreu, Soraia C., et al.
Publicado: (2020)

Intra-vital imaging of mesenchymal stromal cell kinetics in the pulmonary vasculature during infection
por: Masterson, Claire H., et al.
Publicado: (2021)

Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia
por: Devaney, James, et al.
Publicado: (2013)

Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns
por: Masterson, Claire H., et al.
Publicado: (2019)

Differential Effects of Cytokine Versus Hypoxic Preconditioning of Human Mesenchymal Stromal Cells in Pulmonary Sepsis Induced by Antimicrobial-Resistant Klebsiella pneumoniae
por: Byrnes, Declan, et al.
Publicado: (2023)

Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020)

Umbilical cord-derived CD362(+) mesenchymal stromal cells for E. coli pneumonia: impact of dose regimen, passage, cryopreservation, and antibiotic therapy
por: Horie, Shahd, et al.
Publicado: (2020)

Clinically relevant concentrations of beta agonists may stimulate alveolar fluid clearance in acute respiratory distress syndrome
por: Perkins, G, et al.
Publicado: (2004)

Bioartificial lungs based on de- and recellularisation approaches: a historical perspective
por: Rolandsson Enes, Sara, et al.
Publicado: (2020)

MSCs interaction with the host lung microenvironment: An overlooked aspect?
por: Weiss, Daniel J., et al.
Publicado: (2022)

Assessing the quantity of pulmonary edema in critically ill children
por: McAuley, Daniel F, et al.
Publicado: (2010)

Nebulized mesenchymal stem cell derived conditioned medium ameliorates Escherichia coli induced pneumonia in a rat model
por: González, Héctor E., et al.
Publicado: (2023)

Umbilical Cord-Derived CD362(+) Mesenchymal Stromal Cells Attenuate Polymicrobial Sepsis Induced by Caecal Ligation and Puncture
por: Gonzalez, Hector, et al.
Publicado: (2020)

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012)

Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases
por: Elowsson Rendin, Linda, et al.
Publicado: (2021)

Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS
por: Dutra Silva, Johnatas, et al.
Publicado: (2021)

Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial
por: Agus, A., et al.
Publicado: (2017)

Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
por: Horie, Shahd, et al.
Publicado: (2016)

Overexpression of IL-10 Enhances the Efficacy of Human Umbilical-Cord-Derived Mesenchymal Stromal Cells in E. coli Pneumosepsis
por: Jerkic, Mirjana, et al.
Publicado: (2019)

Delayed MSC therapy enhances resolution of organized pneumonia induced by antibiotic resistant Klebsiella pneumoniae infection
por: Byrnes, Declan, et al.
Publicado: (2023)

The interaction between arterial oxygenation and carbon dioxide and hospital mortality following out of hospital cardiac arrest: a cohort study
por: McGuigan, Peter J., et al.
Publicado: (2020)

Effect of sustained inflation recruitment maneuvers on lung endothelial and alveolar epithelial injury in experimental acute lung injury
por: Frank, J, et al.
Publicado: (2004)

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial
por: Gorman, Ellen, et al.
Publicado: (2021)

Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases
por: Silva, Luisa H. A., et al.
Publicado: (2018)

Acidosis in the critically ill - balancing risks and benefits to optimize outcome
por: Curley, Gerard F, et al.
Publicado: (2014)

Cell therapy demonstrates promise for acute respiratory distress syndrome - but which cell is best?
por: Curley, Gerard F, et al.
Publicado: (2013)

Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014)

Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis
por: Carla, Adrien, et al.
Publicado: (2020)

Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial
por: Gorman, Ellen, et al.
Publicado: (2020)

Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS?
por: Curley, Gerard, et al.
Publicado: (2011)

Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS
por: Wick, Katherine D., et al.
Publicado: (2021)

Overexpression of pulmonary extracellular superoxide dismutase attenuates endotoxin-induced acute lung injury
por: Hassett, Patrick, et al.
Publicado: (2011)

Mesenchymal Stromal Cell Extracellular Vesicles: A New Approach for Preventing Bronchopulmonary Dysplasia?
por: Klinger, James R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dlkkmraileoaei16jd54cju7re